1. Home
  2. MD vs BHVN Comparison

MD vs BHVN Comparison

Compare MD & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pediatrix Medical Group Inc.

MD

Pediatrix Medical Group Inc.

N/A

Current Price

$25.91

Market Cap

2.2B

Sector

Health Care

ML Signal

N/A

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

N/A

Current Price

$13.31

Market Cap

2.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MD
BHVN
Founded
1979
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Hospital/Nursing Management
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.3B
IPO Year
1996
2022

Fundamental Metrics

Financial Performance
Metric
MD
BHVN
Price
$25.91
$13.31
Analyst Decision
Hold
Buy
Analyst Count
4
14
Target Price
$20.50
$29.08
AVG Volume (30 Days)
638.9K
3.4M
Earning Date
05-05-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
263.03
26.08
EPS
0.85
N/A
Revenue
$1,913,849,000.00
N/A
Revenue This Year
$3.72
N/A
Revenue Next Year
$2.62
N/A
P/E Ratio
$31.21
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.70
$7.48
52 Week High
$28.86
$18.57

Technical Indicators

Market Signals
Indicator
MD
BHVN
Relative Strength Index (RSI) 48.83 36.40
Support Level $25.24 $8.75
Resistance Level $27.23 $13.54
Average True Range (ATR) 0.79 0.99
MACD -0.04 -0.39
Stochastic Oscillator 53.81 6.09

Price Performance

Historical Comparison
MD
BHVN

About MD Pediatrix Medical Group Inc.

Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Share on Social Networks: